We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
+$1.62M
(+4%)
Cap. Flow
-$1.13M
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
72.84%
Holding
48
New
–
Increased
1
Reduced
16
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$257K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$616K |
| 2 |
Qualcomm
QCOM
|
+$166K |
| 3 |
Honeywell
HON
|
+$83.3K |
| 4 |
Apple
AAPL
|
+$83K |
| 5 |
Onto Innovation
ONTO
|
+$78.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.93% |
| 2 | Healthcare | 15.21% |
| 3 | Energy | 13.88% |
| 4 | Financials | 12.92% |
| 5 | Industrials | 6.09% |
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Tanaka Capital Management held 48 positions worth $42.2M, up 4% from $40.6M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 2.1%. Tanaka Capital Management opened no new positions and exited 1, leaving the 48-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 37% a quarter earlier, followed by Healthcare and Energy.
- Tanaka Capital Management added most to Corcept Therapeutics in Q2 2024, an estimated $257K increase.
- Tanaka Capital Management's biggest Q2 2024 reduction was Qualcomm, cutting an estimated $166K.
- Tanaka Capital Management fully exited Tesla in Q2 2024, selling an estimated $616K.
- Tanaka Capital Management's ten largest holdings make up 73% of its $42.2M portfolio in Q2 2024.
- Tanaka Capital Management opened 0 new positions and closed 1 in Q2 2024.
- Tanaka Capital Management's portfolio value rose 4% quarter-over-quarter to $42.2M.
Based on Tanaka Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.